PRESS RELEASE published on 09/03/2026 at 19:15, 1 month 27 days ago Inside Information / Other news releases Laure-Hélène Mercier appointed as Chair of Poxel's Board of Directors, enhancing governance and financial oversight. Sophie Jacq Lapointe steps down with gratitude. Poxel focuses on metabolic diseases and HCM treatments Governance Metabolic Diseases Poxel Laure-Hélène Mercier HCM
PRESS RELEASE published on 09/03/2026 at 19:15, 1 month 27 days ago Informations privilégiées / Autres communiqués Laure-Hélène Mercier nommée Présidente du Conseil d'administration de Poxel en remplacement de Sophie Jacq Lapointe. Renforcement de la gouvernance et du contrôle financier Gouvernance Conseil D'administration Biopharmaceutique Poxel Laure-Hélène Mercier
BRIEF published on 07/30/2026 at 21:35, 3 months ago Poxel : Résultats du 2ème trimestre 2026 et report des comptes 2025 Chiffre D'affaires TWYMEEG® Poxel Sumitomo Pharma Comptes 2025
BRIEF published on 07/30/2026 at 21:35, 3 months ago Poxel enregistre un chiffre d'affaires positif malgré le report de la publication de ses résultats financiers États Financiers Redevance Poxel Ventes TWYMEEG® Évaluation De La Dette
BRIEF published on 07/30/2026 at 21:35, 3 months ago Poxel Records Positive Turnover amidst Financial Statement Postponement Financial Statements Royalties Poxel TWYMEEG® Sales Debt Valuation
BRIEF published on 07/30/2026 at 21:35, 3 months ago Poxel: Q2 2026 Results and 2025 Financial Statements Report Revenue TWYMEEG® Poxel Sumitomo Pharma 2025 Accounts
PRESS RELEASE published on 07/30/2026 at 21:30, 3 months ago Informations privilégiées / Autres communiqués Poxel publie son chiffre d'affaires pour le deuxième trimestre 2026 et annonce le report de la publication des comptes 2025. Les ventes de TWYMEEG® au Japon en forte croissance Chiffre D'affaires Croissance Report Poxel TWYMEEG
PRESS RELEASE published on 07/30/2026 at 21:30, 3 months ago Inside Information / Other news releases Poxel publishes Q2 2026 turnover & delays 2025 financial statements release. TWYMEEG(R) net sales up in Japan, reaching 2.9 billion yen; royalty rate to increase Financial Statements Turnover Royalties Poxel TWYMEEG
BRIEF published on 06/10/2026 at 20:18, 4 months 20 days ago Poxel nomme Yves Decadt PDG pour faire progresser ses objectifs stratégiques Partenariats Stratégiques Biopharmaceutique Poxel Iméglimine Yves Decadt
BRIEF published on 06/10/2026 at 20:18, 4 months 20 days ago Poxel appoints Yves Decadt as its new Chief Executive Officer Strategic Partnerships Biopharmaceutical Continuation Plan Poxel Yves Decadt
Published on 10/30/2026 at 23:35, 13 hours 16 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 13 hours 21 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 16 hours 4 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 17 hours 51 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 21 hours 21 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 14 hours 2 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 18 hours 13 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 13 hours 51 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 13 hours 51 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
